Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANDIN for Common Warts
NCT02393417Phase 2Completed
- Sponsor
- Nielsen BioSciences, Inc.
- Start
- Mar 2015
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of candida albicans extract in common warts, sponsored by Nielsen BioSciences, Inc.. Started Mar 2015; status: completed.
02
Drugs
candida albicans extract
03
Conditions
common warts
Beyond the preview
Go deeper on NCT02393417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393417.